logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Neuroinflammation From Bench To Bedside 1st Edition H Kettenmann Auth

  • SKU: BELL-4460980
Neuroinflammation From Bench To Bedside 1st Edition H Kettenmann Auth
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Neuroinflammation From Bench To Bedside 1st Edition H Kettenmann Auth instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 5.66 MB
Pages: 238
Author: H. Kettenmann (auth.), H. Kettenmann, G. A. Burton, U. J. Moenning (eds.)
ISBN: 9783662050736, 9783662050750, 3662050730, 3662050757
Language: English
Year: 2002
Edition: 1

Product desciption

Neuroinflammation From Bench To Bedside 1st Edition H Kettenmann Auth by H. Kettenmann (auth.), H. Kettenmann, G. A. Burton, U. J. Moenning (eds.) 9783662050736, 9783662050750, 3662050730, 3662050757 instant download after payment.

Recent work has implicated inflammatory processes in the pathophysiology of a variety of neurodegenerative diseases such as Alzheimer's disease, stroke and multiple sclerosis. In this book leading experts in the field discuss molecular, in vivo and clinical aspects of neuroinflammation. It is hoped, with the wealth of research being conductied in this area, that novel therapeutic targets will be identified which will allow successful therapeutic intervention in a variety of neurodegenerative diseases.

Related Products